Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
ADAM-17 predicts adverse outcome in patients with breast cancer. [electronic resource] by
- McGowan, P M
- McKiernan, E
- Bolster, F
- Ryan, B M
- Hill, A D K
- McDermott, E W
- Evoy, D
- O'Higgins, N
- Crown, J
- Duffy, M J
Producer: 20080721
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 19
Availability: No items available.
|
|
32.
|
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. [electronic resource] by
- Ryan, B M
- Konecny, G E
- Kahlert, S
- Wang, H-J
- Untch, M
- Meng, G
- Pegram, M D
- Podratz, K C
- Crown, J
- Slamon, D J
- Duffy, M J
Producer: 20060927
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 17
Availability: No items available.
|